Oleanolic acid inhibits the malignant progression of CML cells through the miR-18a-5p/STK4 axis
Authors:
Preprint
- 20 November 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Chronic myeloid leukemia (CML) is a malignant tumor that affects the blood and bone marrow. Its characteristic is the production of a large number of immature white blood cells, which aggregate in the bone marrow and inhibit normal hematopoiesis in the bone marrow. To date, CML is mainly treated through the use of tyrosine kinase inhibitors and hematopoietic stem cell transplantation. However, some patients may experience resistance to tyrosine kinase inhibitors and rejection reactions after transplantation of hematopoietic stem cells. In previous experiments, we found that oleanolic acid (OA) promoted an increase in reactive oxygen species (ROS) in K562 cells, decreased mitochondrial membrane potential, and decreased cell proliferation ability. Flow cytometry and CCK8 experiments have shown that OA can lead to the occurrence of cell apoptosis in a dose-dependent manner. Through further experiments, we found that after OA treatment, STK4 expression was upregulated and miRNA-18a-5p expression was downregulated in K562 cells. Surprisingly, the addition of miRNA-18a-5p mimics inhibited the expression of STK4 in cells; after adding the miRNA inhibitor, the expression of STK4 increased. Further research has shown that after overexpression of STK4, compared with the control group, the mitochondrial membrane potential of cells decreases and the proliferation ability significantly decreases. After interfering with STK4 and undergoing OA treatment, compared with the OA group, the decrease in mitochondrial membrane potential in the interference + OA group was inhibited, and the cell proliferation ability returned to the level of the control group. OA can maintain low expression of STK4 in K562 cells by upregulating miR-18a, which directly targets the STK4 mRNA 3'UTR. Downregulation of miR-18a increases STK4 expression. Our research results confirm that OA can promote apoptosis in K562 cells by maintaining low expression of miR-18a and keeping STK4 in a high expression state.Keywords
All Related Versions
This publication has 24 references indexed in Scilit:
- miR-18a counteracts AKT and ERK activation to inhibit the proliferation of pancreatic progenitor cellsScientific Reports, 2017
- STK4 regulates TLR pathways and protects against chronic inflammation–related hepatocellular carcinomaJournal of Clinical Investigation, 2015
- microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemiaNeoplasma, 2015
- Oleanolic acid suppresses the proliferation of lung carcinoma cells by miR-122/Cyclin G1/MEF2D axisMolecular and Cellular Biochemistry, 2014
- MicroRNA-18a is elevated in prostate cancer and promotes tumorigenesis through suppressing STK4 in vitro and in vivoOncogenesis, 2014
- Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancerGastric Cancer, 2014
- Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohortBreast Cancer Research, 2013
- microRNA expression profile in stage III colorectal cancer: Circulating miR-18a and miR-29a as promising biomarkersOncology Reports, 2013
- Oleanolic acidPhytochemistry, 2012
- Mechanisms of BCR–ABL in the pathogenesis of chronic myelogenous leukaemiaNature Reviews Cancer, 2005